The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ando Goran since 2006.
This trader's CIK number is 1110748.
At the time of last reporting, Ando Goran was the Officer of Eyepoint Pharmaceuticals, Inc.. (stock ticker symbol EYPT).
Also see all insider trading activities at Eyepoint Pharmaceuticals, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2009 | ENZN | 0 | $0 | 0 | $0 | 4,279 | $0 |
2008 | ENZN | 15,000 | $56,505 | 0 | $0 | 5,532 | $0 |
2007 | ENZN | 0 | $0 | 0 | $0 | 2,360 | $0 |
2006 | ENZN | 0 | $0 | 0 | $0 | 1,255 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2024 | EYPT | 5,000 | $39,750 | 0 | $0 | 0 | $0 |
2023 | EYPT | 0 | $0 | 0 | $0 | 3,250 | $0 |
2022 | EYPT | 0 | $0 | 0 | $0 | 2,750 | $0 |
2021 | EYPT | 0 | $0 | 0 | $0 | 2,150 | $0 |
1. Enzon Pharmaceuticals, Inc. (ENZN)
2. Eyepoint Pharmaceuticals, Inc. (EYPT)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2009-07-02 | ENZN | Option Ex | 3,173 | .00 | 0 |
2009-07-03 | ENZN | Option Ex | 1,106 | .00 | 0 |
2008-11-14 | ENZN | Buy | 15,000 | 3.77 | 56,505 |
2008-07-01 | ENZN | Option Ex | 1,255 | .00 | 0 |
2008-07-02 | ENZN | Option Ex | 3,172 | .00 | 0 |
2008-07-03 | ENZN | Option Ex | 1,105 | .00 | 0 |
2007-07-01 | ENZN | Option Ex | 1,255 | .00 | 0 |
2007-07-03 | ENZN | Option Ex | 1,105 | .00 | 0 |
2006-07-01 | ENZN | Option Ex | 1,255 | .00 | 0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-08-21 | EYPT | Buy | 5,000 | 7.95 | 39,750 |
2023-02-09 | EYPT | Option Ex | 3,250 | .00 | 0 |
2022-02-09 | EYPT | Option Ex | 2,750 | .00 | 0 |
2021-02-28 | EYPT | Option Ex | 2,150 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ando Goran (Officer of Eyepoint Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.